The immunoassay market is expected to reach USD 27.15 billion by 2023 from USD 20.19 billion in 2018, at a CAGR of 6.1 percent. The increasing incidence of chronic and infectious diseases, technological advancements in immunoassay instruments and introduction of novel automated systems, and growth in the biotechnology and biopharmaceutical industries are some the major factors driving the growth of this market.

On the basis product and service, in 2017, the reagents and kits segment accounted for the largest share of the immunoassays market. The large share of this segment can primarily be attributed to the requirement of the repeat purchase of kits and reagents, coupled with the increasing number of immunoassay tests being performed across the globe as a result of the rising incidence of chronic and infectious diseases. By platform, the CLIAs segment accounted for the largest share of the immunoassays market in 2017. The large share of this segment can primarily be attributed to the low cost and high sensitivity of CLIA-based tests.

On the basis of technology, the ELISA segment accounted for the largest share of the immunoassays market in 2017. The large share of this segment can primarily be attributed to the increasing use of immunoassay tests in cancer, infectious diseases, and therapeutic drug level monitoring. Based on region, North America dominated the market in 2017. The large share of this regional segment is attributed to the increasing incidence of chronic diseases and improved healthcare infrastructure.

Key players in the immunoassays market include Roche (Switzerland), Abbott Laboratories (US), Siemens (Germany), Danaher Corporation (US), Sysmex Corporation (Japan), bioMérieux (France), Ortho Clinical Diagnostics (US), DiaSorin (Italy), QIAGEN (Netherlands), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Merck (Germany), Bio-Rad Laboratories (US), Agilent Technologies (US), PerkinElmer (US), Quidel Corporation (US), Bio-Techne Corporation (US), and Mindray (China). – MarketsandMarkets


10 Diagnostic Imaging Trends for 2018

Video

 

Digital version